Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
We accept In stock Ships today if ordered by 3 PM EST USA fulfillment COA on request 3rd-party tested 24 h dispatch Certificate of Analysis current lot Verified Batch / Lot # GP-6482-2025 Test date May 2, 2026 Laboratory Freedom Diagnostics Identity / Purity (HPLC) 99.70% Mass confirmation (LC-MS) Match Endotoxin (LAL, USP ) 0.40 EU/mg Residual solvents (USP ) Pass Water content (KF) Pass Description Reviews Retatrutide 10 mg Research Grade (Bulk Vial) Retatrutide is a synthetic triple-agonist research peptide targeting the GLP-1, GIP, and glucagon receptors simultaneously
GLP-1 MEDICATIONS There are currently two classes of GLP-1 receptor agonists available for weight loss: semaglutide and tirzepatide
YF: Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Writing original draft
Novo Nordisk (the maker of Wegovy) and Eli Lilly (the maker of Zepbound) have both decreased the price of these weight loss drugs for people who are paying out of pocket or do not have insurance coverage for weight loss drugs
US$ 21.85
US$ 21.33
US$ 23.43
